6MK.F

Merck & Co., Inc.
FrankfurtEUREQUITY Healthcare DELAYED
Last price
131.06
▲ 1.88 (1.46%)
MARKET ·

Price

Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
127.24
Prev close
129.18
Day high
132.00
Day low
127.24
Volume
2.98K
Market cap
$323.35B
P/E (TTM)
122.49
52W range
66.40 – 132.00

Day trading desk

Current session · delayed
Gap from prior close
-1.50%
Prior close 129.18
VWAP
129.83
+0.95% from price
Relative volume
13.56×
Unusually busy
Session range
3.74%
127.24 – 132.00
Position in range
80%
Near session high
ATR (14D)
2.49
1.90% of price
Prior day high
130.62
PDH
Prior day low
128.00
PDL
Bid / ask spread
Quote not published
Session volume
5.93K
Avg 437

VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.

Trailing performance

Price return · vs SPY
Returnvs SPY
1W
+12.89% +14.3%
1M
+14.14% +10.4%
3M
+25.90% +22.8%
6M
+25.30% +14.2%
YTD
+45.14% +32.8%
1Y
+76.16% +56.2%
3Y
+29.76% -44.4%
5Y
+111.11%

Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.

Unusual options activity

Account required
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
Free account required

Contracts trading at or above their open interest, ranked by notional and where the print landed.

Free account

5 more panels on 6MK.F open with an account.

Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.

Insider net activity

6m · Form 4 rollup
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
Net transactions
0
Buys less sells
Sell : buy shares
Not enough filings
Insider-held shares
1.38M
Total on file

Insider transactions

Account required
DateInsiderAction SharesValueHeld
Aug 13, 26
GUINDO CHIRFI
Officer
SELL 10.00K $1.35M Direct
Aug 12, 26
ZACHARY JENNIFER L
General Counsel
CONVERSION 54.93K $6.03M Direct
Aug 12, 26
DELUCA RICHARD ROBERT JR.
Officer
SELL 45.32K $5.94M Direct
Aug 12, 26
ZACHARY JENNIFER L
General Counsel
SELL 80.31K $10.72M Direct
Aug 6, 26
DELUCA RICHARD ROBERT JR.
Officer
SELL 6.05K $788.77K Direct
Aug 6, 26
GUINDO CHIRFI
Officer
SELL 15.00K $1.97M Direct
Aug 5, 26
WILLIAMS DAVID MICHAEL
Chief Technology Officer
CONVERSION 52.85K $3.94M Direct
Aug 5, 26
MARALDO DAVID R.
Officer
CONVERSION 18.71K $1.54M Direct
Aug 5, 26
WILLIAMS DAVID MICHAEL
Chief Technology Officer
SELL 52.85K $6.81M Direct
Aug 5, 26
MARALDO DAVID R.
Officer
SELL 18.71K $2.41M Direct
May 1, 26
SMART DALTON E. III
Officer
CONVERSION 383 $42.96K Direct
May 1, 26
MARALDO DAVID R.
Officer
CONVERSION 552 $61.91K Direct
Apr 30, 26
LARSON BETTY D
Officer
13.44K Direct
Apr 30, 26
SMART DALTON E. III
Officer
CONVERSION 1.41K $155.35K Direct
What this is, and what it is not

These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.

A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.

This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.

Free account required

Officer and director trades in their own stock, straight from Form 4 filings.

Insider holders

10 reporting
NameRelationShares heldLatest
CHATTOPADHYAY SANAT
Officer 200.68K Conversion of Exercise of derivative security
DAVIS ROBERT M
Chief Executive Officer 450.35K Conversion of Exercise of derivative security
DELUCA RICHARD ROBERT JR.
Officer 110.17K Sale
GUINDO CHIRFI
Officer 36.61K Sale
LI DEAN Y
Officer 94.43K Conversion of Exercise of derivative security
LITCHFIELD CAROLINE
Chief Financial Officer 92.30K Conversion of Exercise of derivative security
OOSTHUIZEN JOHANNES JACOBUS
Officer 21.89K Conversion of Exercise of derivative security
ROMANELLI JOSEPH EDWARD
Officer 28.74K Stock Award(Grant)
WILLIAMS DAVID MICHAEL
Chief Technology Officer 31.72K Conversion of Exercise of derivative security
ZACHARY JENNIFER L
General Counsel 45.51K Conversion of Exercise of derivative security

Fundamentals

TTM · reported
Market cap$323.35B
Enterprise value$370.17B
Revenue (TTM)$66.57B
Gross profit$50.53B
EBITDA$28.87B
Net income$3.17B
EPS (TTM)$1.07
Free cash flow$15.17B
Total cash$7.14B
Total debt$53.91B
Book value / share$14.68
Shares outstanding2.47B
Float2.46B
Short % of float
Dividend yield2.28%
Beta (5Y)0.21

Valuation & profitability ratios

Account required
Trailing P/E122.49
Forward P/E
PEG ratio10.51
Price / sales
Price / book8.93
EV / revenue5.56
EV / EBITDA12.82
Gross margin75.90%
Operating margin-0.24%
Profit margin4.77%
Return on equity6.96%
Return on assets11.87%
Debt / equity128.41
Current ratio1.32
Free account required

Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.

Financial statements

As reported · 4 years · 6 quarters
Blank means not reported, not zero
Line item2025202420232022YoY
Total revenue $65.01B$64.17B$60.12B$59.28B +1.3%
Operating revenue $65.01B$64.17B$60.12B$59.28B +1.3%
Cost of revenue $16.38B$15.19B$16.13B$17.41B +7.8%
Gross profit $48.63B$48.98B$43.99B$41.87B -0.7%
Research & development $15.79B$17.94B$30.53B$13.55B -12.0%
Selling, general & admin $10.73B$10.82B$10.50B$10.04B -0.8%
Total operating expense $26.52B$28.75B$41.03B$23.59B -7.8%
Operating income $22.11B$20.22B$2.95B$18.28B +9.3%
Net interest income -$1.01B-$856.00M-$781.00M-$805.00M -18.5%
Pre-tax income $21.07B$19.94B$1.89B$16.44B +5.7%
Tax provision $2.80B$2.80B$1.51B$1.92B +0.0%
Net income $18.25B$17.12B$365.00M$14.52B +6.6%
Net income to common $18.25B$17.12B$365.00M$14.52B +6.6%
Basic EPS 7.386.770.145.73 +8.9%
Diluted EPS 7.286.740.145.71 +8.0%
EBIT $22.42B$21.21B$3.04B$17.41B +5.7%
EBITDA $28.26B$25.71B$6.91B$21.32B +9.9%
Basic shares 2.47B2.53B2.61B2.53B -2.1%
Diluted shares 2.51B2.54B2.61B2.54B -1.3%

Options analytics

Account required
Put / call volume
Put / call open interest
Positioning, not flow
Max pain
ATM implied vol
Nearest strike to spot
Skew (10% OTM)
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
Heaviest put OI

Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.

Free account required

Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.

Earnings

History & consensus estimates
Forward consensus
PeriodEPSAnalystsRevenueGrowth
Current quarter $17.34B +0.4%
Next quarter $16.87B +2.8%
Current year $67.14B +3.3%
Next year $70.28B +4.7%

Analyst targets & ownership

Account required
Mean target
High target
Low target
Implied upside
Analyst count
ConsensusNONE
Strong buy / Buy— / —
Hold
Sell / Strong sell— / —
Held by insiders0.06%
Held by institutions82.73%
Institutions holding4.83K
Free account required

Price targets, consensus spread, insider and institutional ownership.

Moving averages & technicals

Computed from 2Y daily closes
SMA 10
119.59
+9.59% from price
SMA 20
116.44
+12.56% from price
SMA 50
111.42
+17.63% from price
SMA 100
105.65
+24.05% from price
SMA 200
99.47
+31.76% from price
EMA 12
120.77
+8.52% from price
EMA 26
116.48
+12.52% from price
EMA 50
112.55
+16.44% from price
RSI (14)
78.4
Overbought
MACD (12,26,9)
4.29
Hist 1.77
ATR (14)
2.49
1.90% of price
Realised vol 30D
37.4%
Annualised
Bollinger upper
128.70
20, 2σ
Bollinger lower
104.18
20, 2σ
50 / 200 cross
Golden
111.42 vs 99.47
Trend bias
Above 200
+31.76%

Options chain

Account required
ExpirySpot 131.06
Calls
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Puts
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Free account required

Every listed expiry, both sides of the book, with volume, open interest and implied volatility.

Risk profile

Daily returns · 1Y window
Beta vs SPY
-0.15
Less volatile than market
Correlation to SPY
-0.06
Largely independent
Realised vol 30D
37.4%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-11.1%
Peak to trough
Max drawdown 5Y
-47.1%
Peak to trough
ATR 14
2.49
1.90% of price
Beta (reported)
0.21
5Y monthly, from filing

Rating changes

363 on file
DateFirm ActionFromTo
Aug 21, 26 Goldman Sachs MAINTAINED Buy Buy
Aug 20, 26 BMO Capital MAINTAINED Outperform Outperform
Aug 20, 26 UBS MAINTAINED Buy Buy
Aug 20, 26 RBC Capital DOWNGRADE Outperform Sector Perform
Aug 20, 26 Morgan Stanley UPGRADE Equal-Weight Overweight
Aug 12, 26 Daiwa Capital UPGRADE Neutral Outperform
Aug 11, 26 Argus Research MAINTAINED Buy Buy
Aug 5, 26 Guggenheim MAINTAINED Buy Buy
Jul 29, 26 Barclays MAINTAINED Overweight Overweight
Jul 13, 26 JP Morgan MAINTAINED Overweight Overweight
Jul 13, 26 BMO Capital MAINTAINED Outperform Outperform
Jul 13, 26 Guggenheim MAINTAINED Buy Buy

Dividends & splits

Declared · from the issuer
Forward rate$2.99 / yr
Forward yield2.28%
5-year avg yield3.01%
Payout ratio268.80%
Ex-dividend dateSep 15, 2026
Next pay date
Last split
Split date

PRIVATE STRATEGY · BY QUALIFICATION

The same data. A different seat.

The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.